NCT06427850View on ClinicalTrials.gov

Effect of Topical Tranexamic Acid on Postoperative Drainage in Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF)

NANot yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Degenerative Spine DiseasesSurgical Wound
Interventions
DRUG

Tranexamic acid

receive an injection of Tranexamic acid into the surgical site

DRUG

Normal saline

receive an injection of Normal saline into the surgical site

All Listed Sponsors
lead

Thanawan Longsuwan

OTHER

NCT06427850 - Effect of Topical Tranexamic Acid on Postoperative Drainage in Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF) | Biotech Hunter | Biotech Hunter